GSTSX
Price
$10.73
Change
-$0.00 (-0.00%)
Updated
Nov 12 closing price
RGACX
Price
$79.25
Change
-$0.15 (-0.19%)
Updated
Nov 13 closing price
Ad is loading...

GSTSX vs RGACX

Header iconGSTSX vs RGACX Comparison
Open Charts GSTSX vs RGACXBanner chart's image
Goldman Sachs Strategic Growth Svc
Price$10.73
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
American Funds Growth Fund of Amer R3
Price$79.25
Change-$0.15 (-0.19%)
VolumeN/A
CapitalizationN/A
GSTSX vs RGACX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GSTSX vs. RGACX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSTSX is a Buy and RGACX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RGACX has more cash in the bank: 306B vs. GSTSX (203M). RGACX pays higher dividends than GSTSX: RGACX (0.25) vs GSTSX (0.00). GSTSX was incepted earlier than RGACX: GSTSX (25 years) vs RGACX (23 years). GSTSX is a more actively managed with annual turnover of: 33.00 vs. RGACX (31.00). GSTSX has a lower initial minimum investment than RGACX: GSTSX (0) vs RGACX (250). RGACX (33.97) and GSTSX (32.35) have marching annual gain over last year. RGACX return over 5 years is better than : 57.18 vs. GSTSX (12.61).
GSTSXRGACXGSTSX / RGACX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence25 years23 years-
Gain YTD29.15729.65498%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets203M306B0%
Annual Yield % from dividends0.000.25-
Returns for 1 year32.3533.9795%
Returns for 3 years-13.48-2.24603%
Returns for 5 years12.6157.1822%
Returns for 10 years-21.9372.30-30%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DLO9.350.70
+8.15%
DLocal Limited
FCUV0.250.01
+4.81%
Focus Universal
AEM77.15-0.98
-1.25%
Agnico Eagle Mines Ltd
ZIP10.25-0.77
-6.99%
ZipRecruiter
ZNTL3.72-0.31
-7.69%
Zentalis Pharmaceuticals